Escalon Medical Corp.
ESMC
$0.2922
-$0.0015-0.51%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.89% | 12.25% | -5.56% | 10.72% | -21.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.89% | 12.25% | -5.56% | 10.72% | -21.51% |
| Cost of Revenue | 18.72% | 2.41% | -4.89% | 19.23% | -8.26% |
| Gross Profit | 43.26% | 24.78% | -6.40% | 0.94% | -34.82% |
| SG&A Expenses | 3.72% | -1.87% | -0.07% | 7.87% | 19.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.13% | 0.85% | -5.14% | 13.74% | 0.26% |
| Operating Income | 276.25% | 462.98% | -73.08% | -32.50% | -126.56% |
| Income Before Tax | 267.49% | 422.41% | -51.89% | -32.26% | -127.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 267.49% | 422.41% | -51.89% | -32.26% | -127.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 267.49% | 422.41% | -51.89% | -32.26% | -127.70% |
| EBIT | 276.25% | 462.98% | -73.08% | -32.50% | -126.56% |
| EBITDA | 286.14% | 555.14% | -254.35% | -26.94% | -125.45% |
| EPS Basic | 177.54% | 238.33% | -32.61% | 8,100.00% | -130.57% |
| Normalized Basic EPS | 267.15% | 423.44% | -50.00% | -32.34% | -127.79% |
| EPS Diluted | 177.54% | 238.33% | -117.39% | 8,100.00% | -155.53% |
| Normalized Diluted EPS | 187.59% | 270.31% | -50.00% | 25.56% | -150.55% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 91.04% | 89.90% | 0.00% | -46.34% | -44.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |